ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004